Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Markusic

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|September 30, 2016
Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycinMoanaro Biswas, Geoffrey L Rogers, Alexandra Sherman, et al.
Plos One|June 2, 2012
Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapyBrandon K Sack, Sherin Merchant, David M Markusic, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2017
Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple SclerosisGeoffrey D Keeler, Sandeep Kumar, Brett Palaschak, et al.
Human Gene Therapy|March 30, 2020
Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune ResponseHyung-Joo Kwon, Keyun Qing, Selvarangan Ponnazhagan, et al.
Human Gene Therapy|July 14, 2020
Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia BHarrison C Brown, Christopher B Doering, Roland W Herzog, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2014
Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variantsDamien Marsic, Lakshmanan Govindasamy, Seth Currlin, et al.
Viruses|July 27, 2024
Viral Vector Based Immunotherapy for Peanut AllergyMiguel Gonzalez-Visiedo, Roland W Herzog, Maite Munoz-Melero, et al.
EMBO Molecular Medicine|October 10, 2013
Effective gene therapy for haemophilic mice with pathogenic factor IX antibodiesDavid M Markusic, Brad E Hoffman, George Q Perrin, et al.
Journal of Translational Medicine|May 3, 2017
Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine modelsDavid M Markusic, Timothy C Nichols, Elizabeth P Merricks, et al.
Journal of Innate Immunity|January 24, 2015
Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene TransferGeoffrey L Rogers, Masataka Suzuki, Irene Zolotukhin, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|September 30, 2016
Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycinMoanaro Biswas, Geoffrey L Rogers, Alexandra Sherman, et al.
Plos One|June 2, 2012
Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapyBrandon K Sack, Sherin Merchant, David M Markusic, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2017
Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple SclerosisGeoffrey D Keeler, Sandeep Kumar, Brett Palaschak, et al.
Human Gene Therapy|March 30, 2020
Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune ResponseHyung-Joo Kwon, Keyun Qing, Selvarangan Ponnazhagan, et al.
Human Gene Therapy|July 14, 2020
Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia BHarrison C Brown, Christopher B Doering, Roland W Herzog, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2014
Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variantsDamien Marsic, Lakshmanan Govindasamy, Seth Currlin, et al.
Viruses|July 27, 2024
Viral Vector Based Immunotherapy for Peanut AllergyMiguel Gonzalez-Visiedo, Roland W Herzog, Maite Munoz-Melero, et al.
EMBO Molecular Medicine|October 10, 2013
Effective gene therapy for haemophilic mice with pathogenic factor IX antibodiesDavid M Markusic, Brad E Hoffman, George Q Perrin, et al.
Journal of Translational Medicine|May 3, 2017
Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine modelsDavid M Markusic, Timothy C Nichols, Elizabeth P Merricks, et al.
Journal of Innate Immunity|January 24, 2015
Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene TransferGeoffrey L Rogers, Masataka Suzuki, Irene Zolotukhin, et al.
Pageof 5